Peer Review reports
From: SSRI use during acute COVID-19 and risk of long COVID among patients with depression
| Original Submission | ||
|---|---|---|
| 25 Mar 2024 | Submitted | Original manuscript |
| 8 Apr 2024 | Reviewed | Reviewer Report |
| 29 Apr 2024 | Reviewed | Reviewer Report |
| 24 May 2024 | Author responded | Author comments - Zachary Butzin-Dozier |
| Resubmission - Version 2 | ||
| 24 May 2024 | Submitted | Manuscript version 2 |
| 8 Jun 2024 | Reviewed | Reviewer Report |
| 24 Sep 2024 | Author responded | Author comments - Zachary Butzin-Dozier |
| Resubmission - Version 3 | ||
| 24 Sep 2024 | Submitted | Manuscript version 3 |
| Publishing | ||
| 25 Sep 2024 | Editorially accepted | |
| 8 Oct 2024 | Article published | 10.1186/s12916-024-03655-x |
You can find further information about peer review here.